The Clorox Company (NYSE:CLX) Receives $155.38 Consensus PT from Analysts

The Clorox Company (NYSE:CLX) has received a consensus recommendation of “Reduce” from the fourteen brokerages that are presently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $155.38.

CLX has been the topic of a number of research analyst reports. JPMorgan Chase & Co. raised their target price on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. DA Davidson raised their price objective on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their target price for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, Barclays upped their price objective on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st.

Institutional Investors Weigh In On Clorox

Institutional investors and hedge funds have recently made changes to their positions in the company. Prospera Private Wealth LLC bought a new position in Clorox during the 3rd quarter valued at about $27,000. Trifecta Capital Advisors LLC increased its holdings in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares in the last quarter. Continuum Advisory LLC raised its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the last quarter. Quarry LP boosted its holdings in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares in the last quarter. Finally, Carolina Wealth Advisors LLC bought a new stake in Clorox during the 3rd quarter worth approximately $48,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Up 0.7 %

CLX opened at $162.89 on Thursday. Clorox has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The business has a 50 day moving average price of $164.58 and a 200 day moving average price of $154.79. The firm has a market cap of $20.16 billion, a P/E ratio of 56.76, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.49 EPS. Research analysts forecast that Clorox will post 6.85 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.00%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.